Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| RETROPHIN | 9 | 9 | +1,74 % | ||
| BEIGENE | 5 | 5 | -0,76 % | ||
| FIBROGEN | 4 | 4 | +0,45 % | ||
| ENDO | 2 | 19 | +1,49 % | ||
| MYLAN | 2 | 3 | +2,24 % | ||
| SAREPTA THERAPEUTICS | 1 | 33 | +1,45 % | ||
| THERAPEUTICSMD | 1 | 5 | -3,11 % | ||
| AMARIN | 1 | 4 | -0,69 % | ||
| CARA THERAPEUTICS | 1 | 4 | -1,89 % | ||
| ARROWHEAD PHARMACEUTICALS | 1 | 3 | +2,04 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:11 | Karyopharm down 1% premarket on publication of mid-stage selinexor data in treatment-resistant multiple myeloma | - | Seeking Alpha | ||
| 14:58 | Retrophin Tanks After Neurological Treatment Fails Late-Stage Study | - | The Street | ||
| 14:34 | Research Solutions, Inc.: Research Solutions to Present at the 8th Annual Gateway Conference on September 4th | - | GlobeNewswire (USA) | ||
| 14:31 | Retrophin Sinks as Drug "Pharma Bro" Martin Shkreli Co-Invented Fails | 1 | Xconomy | ||
| 14:08 | Retrophin's stock plunges after late-stage trial for PKAN treatment fails to meet targets | 1 | MarketWatch | ||
| 14:01 | Incyte to Present at Upcoming Investor Conferences | 108 | Business Wire | Incyte Corporation (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:
Morgan Stanley 17th Annual Global Healthcare Conference... ► Artikel lesen | |
| 13:58 | Rocket Pharma's mid-stage FANCOLEN-II study of RP-L102 cleared in Spain | 1 | Seeking Alpha | ||
| 13:39 | The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study | 1 | Benzinga.com | ||
| 13:22 | Retrophin's fosmetpantotenate flunks late-stage study in rare neurodegenerative disorder; shares down 25% premarket | 1 | Seeking Alpha | ||
| 13:10 | Myriad Genetics, Inc.: Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related ... | - | GlobeNewswire (USA) | ||
| 12:52 | Retrophin: Phase 3 FORT Study Fails To Meet Endpoints | - | RTTNews | ||
| 12:46 | UPDATE 1-Retrophin drug to treat nervous system disorder fails late-stage study | 1 | Reuters.com | ||
| 12:46 | Retrophin neurological disorder drug misses late-stage study main goal | - | Reuters.com | ||
| 12:35 | Retrophin, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12:31 | BeiGene gets speedy US review for lymphoma drug zanubrutinib | - | PMLiVE | ||
| 09:22 | Denmark's Novo Nordisk files lawsuit against Mylan over patent | 32 | Reuters.com | ||
| 01:23 | BEIGENE (06160): INSIDE INFORMATION - BUSINESS UPDATES | 2 | HKEx | ||
| 00:31 | Bayer Aktie & 975 Mio.€ Umsatz in Gefahr?! - Stellt Cannabis eine Alternative zu Aspirin dar? | Cannabisradar-Redaktion | Aspirin ist wohl eines der bekanntesten und auch ältesten Medikamente weltweit. Bereits 1899 zählte Aspirin zu den ersten als Tablettenform verkäuflichen Medikamenten. Könnte nun nach 120 Jahren, das... ► Artikel lesen | ||
| Mi | Karyopharm Therapeutics Inc.: Karyopharm Announces Publication of XPOVIO (Selinexor) Phase 2b STORM Study Results ... | 3 | GlobeNewswire (USA) | ||
| Mi | Kura Oncology files for $200M mixed shelf | - | Seeking Alpha |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
